- Investing Ideas
- Israeli Pharmaceuticals & Biotech Potentially Undervalued Companies
Israeli Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
7
Companies with a Value score of at least 3, ordered by Value score
7 companies
Seach Medical Group
Market Cap: ₪87.1m
Manufactures and sells medicinal cannabis products worldwide.
SEMG
₪2.71
7D
-1.8%
1Y
-3.8%
Tikun Olam-Cannbit Pharmaceuticals
Market Cap: ₪1.2m
Engages in the production, supply, and marketing of cannabis-based products for medical use in Israel.
TKUN-M
₪705.00
7D
24.4%
1Y
-96.2%
Compugen
Market Cap: ₪247.7m
A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.
CGEN
₪7.58
7D
7.7%
1Y
60.7%
InterCure
Market Cap: ₪172.6m
Engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
INCR
₪15.78
7D
10.9%
1Y
-43.7%
Rafa Laboratories
Market Cap: ₪1.5b
A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.
RAFA
₪15.09
7D
4.5%
1Y
n/a
Kamada
Market Cap: ₪1.5b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪25.50
7D
11.5%
1Y
6.0%
BioLineRx
Market Cap: ₪39.3m
A biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.
BLRX
₪0.015
7D
7.1%
1Y
-31.8%